DiaMedica Therapeutics Inc (NAS:DMAC)
$ 2.88 0.03 (1.05%) Market Cap: 109.34 Mil Enterprise Value: 63.20 Mil PE Ratio: 0 PB Ratio: 2.36 GF Score: 36/100

Q4 2019 DiaMedica Therapeutics Inc Earnings Call Transcript

Mar 24, 2020 / 12:00PM GMT
Release Date Price: $2.25 (-2.60%)
Operator

Ladies and gentlemen, thank you for standing by, and welcome to the DiaMedica Therapeutics Inc. Q4 2019 Results Earnings Conference Call. (Operator Instructions)

I would now like to hand the conference over to your speaker today, Rick Pauls, President and Chief Executive Officer. Thank you. Please go ahead, sir.

Dietrich John Pauls
DiaMedica Therapeutics Inc. - President, CEO & Director

Thank you, Lisa. Good morning, everyone. We hope you are all safe and well. We'd like to welcome you to our year-end 2019 earnings and business update call.

Yesterday, after the market close, we issued a press release with a business update and summary of our financial results for 2019. We also filed our annual report on Form 10-K. Both documents can be found in the Investors and Media section of our website at diamedica.com.

With me here today is our Chief Financial Officer, Scott Kellen; and our Chief Medical Officer, Dr. Harry Alcorn.

DiaMedica set out some ambitious goals for 2019. I'm proud of our team, which has accomplished each

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot